Want to see BNTC full AI Analyst Report?
Total Valuation
Benitec Biopharma has a market cap or net worth of $313.60M. The enterprise value is $281.17M.
Market Cap$313.60M
Enterprise Value$281.17M
Share Statistics
Benitec Biopharma has 34,882,725 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,882,725
Owned by Insiders5.52%
Owned by Institutions60.81%
Financial Efficiency
Benitec Biopharma’s return on equity (ROE) is -0.26 and return on invested capital (ROIC) is -28.80%.
Return on Equity (ROE)-0.26
Return on Assets (ROA)-0.25
Return on Invested Capital (ROIC)-28.80%
Return on Capital Employed (ROCE)-0.29
Revenue Per Employee0.00
Profits Per Employee-1.90M
Employee Count24
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Benitec Biopharma is ―. Benitec Biopharma’s PEG ratio is 2.05.
PE Ratio―
PS Ratio0.00
PB Ratio3.52
Price to FCF-37.48
Price to Operating Cash Flow-24.00
PEG Ratio2.05
Income Statement
In the last 12 months, Benitec Biopharma had revenue of 0.00 and earned -45.55M in profits. Earnings per share was -0.98.
Revenue0.00
Gross Profit-481.00K
Operating Income-51.19M
Pretax Income-45.55M
Net Income-45.55M
EBITDA-50.71M
Earnings Per Share (EPS)-0.98
Cash Flow
In the last 12 months, operating cash flow was -16.98M and capital expenditures -106.04K, giving a free cash flow of -17.08M billion.
Operating Cash Flow-16.98M
Free Cash Flow-17.08M
Free Cash Flow per Share-0.49
Dividends & Yields
Benitec Biopharma pays an annual dividend of $0.765, resulting in a dividend yield of 0.12%
Dividend Per Share$0.765
Dividend Yield0.12%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change-38.38%
50-Day Moving Average11.72
200-Day Moving Average11.85
Relative Strength Index (RSI)28.02
Average Volume (3m)156.52K
Important Dates
Benitec Biopharma upcoming earnings date is Nov 16, 2026, After Close (Confirmed).
Last Earnings DateSep 14, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
Benitec Biopharma as a current ratio of 34.00, with Debt / Equity ratio of 0.43%
Current Ratio34.00
Quick Ratio34.00
Debt to Market Cap0.00
Net Debt to EBITDA3.53
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Benitec Biopharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Benitec Biopharma EV to EBITDA ratio is -8.75, with an EV/FCF ratio of -26.69.
EV to Sales0.00
EV to EBITDA-8.75
EV to Free Cash Flow-26.69
EV to Operating Cash Flow-26.86
Balance Sheet
Benitec Biopharma has $179.97M in cash and marketable securities with $762.00K in debt, giving a net cash position of $179.21M billion.
Cash & Marketable Securities$179.97M
Total Debt$762.00K
Net Cash$179.21M
Net Cash Per Share$5.14
Tangible Book Value Per Share$3.80
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Benitec Biopharma is $24.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$24.67
Price Target Upside89.45% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast14.04%